Clinical Trial

Copeptin Measurement After Mannitol and Hypertonic Saline for the Diagnosis of Polyuria-polydipsia Syndrome

Study acronym: COMPASS
Recruiting
View on ClinicalTrials.gov →
Summary
The aim of this study is to evaluate whether a new test using mannitol infusion can diagnose the cause of polyuria-polydipsia syndrome as accurately as the current standard test (hypertonic saline infusion) and to compare which test patients prefer. The goal is to identify a simpler and more patient-friendly diagnostic approach.
Protocol Amendment History 1 change
critical Recruitment opened 2026-06-19
Trial Details
NCT Number NCT07569861
Lead Sponsor University Hospital, Basel, Switzerland
Conditions Arginine Vasopressin Deficiency, Primary Polydipsia
Enrollment 144 participants
Start Date 2026-06-16
Primary Completion 2030-06 (estimated)
Study Completion 2030-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-18